Paper & Presentations [RSABE / ABEL]

posted by Helmut Homepage – Vienna, Austria, 2018-03-30 03:33 (2012 d 17:43 ago) – Posting: # 18622
Views: 9,198

Hi John,

❝ If I recall (or I am imagining things), FDA published a paper about NTI drug BE assessment (Helmut, help! Am I hallucinating again?)


[image]Too much absinthe? I guess you mean this goody:

Yu LX, Jiang W, Zhang X, Lionberger R, Makhlouf F, Schuirmann DF, Muldowney L, Chen M-L, Davit B, Conner D, Woodcock J. Novel Bioequivalence Approach for Narrow Thera­peutic Index Drugs. Clin Pharmacol Ther. 2015;97(3):286–91. doi:10.1002/cpt.28.


❝ Anyhow, Have you looked at this FDA slide presentation before?

NTI


Yep. There are others with more background information. Most simulations were performed in R – Donald told me in 2016 that he grew up with APL and finds R difficult… See also this post. The presentations are gone with the wind. Webarchive [image] #1 (June 2017), [image] #2 (July 2017). In #1 navigate to page 51 and in #2 to page 57.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,764 posts in 4,776 threads, 1,628 registered users;
19 visitors (1 registered, 18 guests [including 4 identified bots]).
Forum time: 21:17 CEST (Europe/Vienna)

The object of statistics is information.
The objective of statistics is the understanding of information
contained in data.    Irwin and Marylees Miller

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5